Header Logo

Camille C Gunderson

TitleProf,Asst
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentObstetrics and Gynecology
AddressSOCC 5050
800 NE 10th St
Oklahoma City OK 73104
Phone405/271-8707
Fax0
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hagemann IS, Deng W, Zaino RJ, Powell MA, Gunderson C, Cosgrove C, Mathews C, Pearl ML, Waggoner S, Ghebre R, Lele S, Guntupalli S, Secord AA, Ioffe O, Park K, Rasty G, Singh M, Soslow R, Creasman W, Mutch DG. The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women. Gynecol Oncol. 2021 Mar; 160(3):660-668. PMID: 33423806.
      Citations:    Fields:    
    2. Elayapillai S, Ramraj S, Benbrook DM, Bieniasz M, Wang L, Pathuri G, Isingizwe ZR, Kennedy AL, Zhao YD, Lightfoot S, Hunsucker LA, Gunderson CC. Potential and mechanism of mebendazole for treatment and maintenance of ovarian cancer. Gynecol Oncol. 2021 01; 160(1):302-311. PMID: 33131904.
      Citations:    Fields:    
    3. Chen X, Liu W, Thai TC, Castellano T, Gunderson CC, Moore K, Mannel RS, Liu H, Zheng B, Qiu Y. Developing a new radiomics-based CT image marker to detect lymph node metastasis among cervical cancer patients. Comput Methods Programs Biomed. 2020 Dec; 197:105759. PMID: 33007594.
      Citations:    Fields:    Translation:Humans
    4. Santin AD, Filiaci V, Bellone S, O'Cearbhaill R, Ratner ES, Mathews CA, Cantuaria G, Gunderson CC, Rutledge T, Buttin BM, Lankes HA, Birrer MJ. Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020) 100532]. Gynecol Oncol Rep. 2020 Aug; 33:100590. PMID: 32885014.
      Citations:    
    5. Zamarin D, Burger RA, Sill MW, Powell DJ, Lankes HA, Feldman MD, Zivanovic O, Gunderson C, Ko E, Mathews C, Sharma S, Hagemann AR, Khleif S, Aghajanian C. Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study. J Clin Oncol. 2020 06 01; 38(16):1814-1823. PMID: 32275468.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    6. Santin AD, Filiaci V, Bellone S, Ratner ES, Mathews CA, Cantuaria G, Gunderson CC, Rutledge T, Buttin BM, Lankes HA, Frumovitz M, Khleif SN, Huh WK, Birrer MJ. Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008). Gynecol Oncol Rep. 2020 Feb; 31:100532. PMID: 31934607.
      Citations:    
    7. Dockery LE, Rubenstein AR, Ding K, Mashburn SG, Burkett WC, Davis AM, Doo DW, Arend RC, Moore KN, Gunderson CC. Extending the platinum-free interval: The impact of omitting 2nd line platinum chemotherapy in intermediate platinum-sensitive ovarian cancer. Gynecol Oncol. 2019 11; 155(2):201-206. PMID: 31522837.
      Citations:    Fields:    Translation:Humans
    8. Moore KN, Gunderson CC, Sabbatini P, McMeekin DS, Mantia-Smaldone G, Burger RA, Morgan MA, Kapoun AM, Brachmann RK, Stagg R, Farooki A, O'Cearbhaill RE. A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer. Gynecol Oncol. 2019 08; 154(2):294-301. PMID: 31174889.
      Citations: 21     Fields:    Translation:HumansCellsCTClinical Trials
    9. Deutsch GB, Deneve JL, Al-Kasspooles MF, Nfonsam VN, Gunderson CC, Secord AA, Rodgers P, Hendren S, Silberfein EJ, Grant M, Sloan J, Sun V, Arnold KB, Anderson GL, Krouse RS. Intellectual Equipoise and Challenges: Accruing Patients With Advanced Cancer to a Trial Randomizing to Surgical or Nonsurgical Management (SWOG S1316). Am J Hosp Palliat Care. 2020 Jan; 37(1):12-18. PMID: 31122027.
      Citations:    Fields:    Translation:Humans
    10. Washington C, Gunderson CC, Moore KN. Update in the use and evaluation of poly (ADP-ribose) polymerase inhibitors in epithelial ovarian cancer: current and pending clinical research. Curr Opin Obstet Gynecol. 2019 02; 31(1):4-11. PMID: 30451713.
      Citations: 3     Fields:    Translation:Humans
    11. Gunderson CC, Erickson BK, Wilkinson-Ryan I, Vesely SK, Leath CA, Gehrig PA, Moore KN. Prospective Evaluation of Multinational Association of Supportive Care in Cancer Risk Index Score for Gynecologic Oncology Patients With Febrile Neutropenia. Am J Clin Oncol. 2019 02; 42(2):138-142. PMID: 30557164.
      Citations: 1     Fields:    Translation:Humans
    12. Zargari A, Du Y, Heidari M, Thai TC, Gunderson CC, Moore K, Mannel RS, Liu H, Zheng B, Qiu Y. Prediction of chemotherapy response in ovarian cancer patients using a new clustered quantitative image marker. Phys Med Biol. 2018 08 06; 63(15):155020. PMID: 30010611.
      Citations: 10     Fields:    Translation:Humans
    13. Du Y, Zhang R, Zargari A, Thai TC, Gunderson CC, Moxley KM, Liu H, Zheng B, Qiu Y. Classification of Tumor Epithelium and Stroma by Exploiting Image Features Learned by Deep Convolutional Neural Networks. Ann Biomed Eng. 2018 Dec; 46(12):1988-1999. PMID: 30051247.
      Citations: 5     Fields:    Translation:Humans
    14. Buechel M, McGinnis A, Vesely SK, Wade KS, Moore KN, Gunderson CC. Consideration of older patients for enrollment in phase 1 clinical trials: Exploring treatment related toxicities and outcomes. Gynecol Oncol. 2018 04; 149(1):28-32. PMID: 29605046.
      Citations: 4     Fields:    Translation:Humans
    15. Temkin SM, Rimel BJ, Bruegl AS, Gunderson CC, Beavis AL, Doll KM. A contemporary framework of health equity applied to gynecologic cancer care: A Society of Gynecologic Oncology evidenced-based review. Gynecol Oncol. 2018 04; 149(1):70-77. PMID: 29605053.
      Citations: 6     Fields:    Translation:Humans
    16. Gunderson CC, Matulonis U, Moore KN. Management of the toxicities of common targeted therapeutics for gynecologic cancers. Gynecol Oncol. 2018 03; 148(3):591-600. PMID: 29395304.
      Citations: 6     Fields:    Translation:Humans
    17. Greenwade MM, Moore KN, Gillen JM, Ding K, Rowland MR, Crim AK, Kleis B, Gunderson CC. Factors influencing clinical trial enrollment among ovarian cancer patients. Gynecol Oncol. 2017 09; 146(3):465-469. PMID: 28689668.
      Citations: 2     Fields:    Translation:Humans
    18. Dockery LE, Gunderson CC, Moore KN. Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer. Onco Targets Ther. 2017; 10:3029-3037. PMID: 28790837.
      Citations:    
    19. Crim A, Rowland M, Ruskin R, Dvorak J, Greenwade M, Walter A, Gillen J, Ding K, Moore K, Gunderson C. Evaluation of the efficacy and toxicity profile associated with intraperitoneal chemotherapy use in older women. Gynecol Oncol. 2017 08; 146(2):268-272. PMID: 28583323.
      Citations: 2     Fields:    Translation:Humans
    20. Danala G, Thai T, Gunderson CC, Moxley KM, Moore K, Mannel RS, Liu H, Zheng B, Qiu Y. Applying Quantitative CT Image Feature Analysis to Predict Response of Ovarian Cancer Patients to Chemotherapy. Acad Radiol. 2017 10; 24(10):1233-1239. PMID: 28554551.
      Citations: 10     Fields:    Translation:Humans
    21. Gillen J, Gunderson C, Greenwade M, Rowland M, Ruskin R, Ding K, Crim A, Walter A, White E, Moore K. Contribution of age to clinical trial enrollment and tolerance with ovarian cancer. Gynecol Oncol. 2017 04; 145(1):32-36. PMID: 28087143.
      Citations: 1     Fields:    Translation:Humans
    22. Prendergast EN, Holzapfel M, Mueller JJ, Leitao MM, Gunderson CC, Moore KN, Erickson BK, Leath CA, Diaz Moore ES, Cohen JG, Walsh CS. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort. Gynecol Oncol. 2017 Feb; 144(2):274-278. PMID: 27979319.
      Citations: 8     Fields:    Translation:Humans
    23. Fader AN, Java J, Tenney M, Ricci S, Gunderson CC, Temkin SM, Spirtos N, Kushnir CL, Pearl ML, Zivanovic O, Tewari KS, O'Malley D, Hartenbach EM, Hamilton CA, Gould NS, Mannel RS, Rodgers W, Walker JL. Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis. Gynecol Oncol. 2016 Dec; 143(3):460-465. PMID: 27743738.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    24. Gunderson CC, Ding K, Dvorak J, Moore KN, McMeekin DS, Benbrook DM. The pro-inflammatory effect of obesity on high grade serous ovarian cancer. Gynecol Oncol. 2016 10; 143(1):40-45. PMID: 27423378.
      Citations: 2     Fields:    Translation:Humans
    25. Gunderson CC, Walter AC, Ruskin R, Ding K, Moore KN. Post-intensive care unit syndrome in gynecologic oncology patients. Support Care Cancer. 2016 11; 24(11):4627-32. PMID: 27306212.
      Citations: 1     Fields:    Translation:Humans
    26. Gunderson CC, Parsons B, Penaroza S, Peyton MD, Landrum LM. Intravenous leiomyomatosis disguised as a large deep vein thrombosis. J Radiol Case Rep. 2016 May; 10(5):29-35. PMID: 27761178.
      Citations: 3     Fields:    Translation:Humans
    27. Slaughter K, Holman LL, Thomas EL, Gunderson CC, Lauer JK, Ding K, McMeekin DS, Moore KM. Primary and acquired platinum-resistance among women with high grade serous ovarian cancer. Gynecol Oncol. 2016 08; 142(2):225-30. PMID: 27208536.
      Citations: 10     Fields:    Translation:Humans
    28. Gunderson CC, Rowland MR, Wright DL, Andrade KL, Mannel RS, McMeekin DS, Moore KN. Initiation of a formalized precision medicine program in gynecologic oncology. Gynecol Oncol. 2016 Apr; 141(1):24-8. PMID: 27016225.
      Citations: 6     Fields:    Translation:Humans
    29. Mueller JJ, Holzapfel M, Han CH, Santos K, Gunderson C, Moore K, Erickson B, Leath CA, Diaz E, Walsh C, Wethington SL, Dejbakhsh SZ, Barakat RR, Gardner GJ, Hyman DM, Soslow RA, Leitao MM. Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary. Int J Gynecol Cancer. 2016 Jan; 26(1):120-4. PMID: 26509849.
      Citations: 6     Fields:    Translation:Humans
    30. Levinson KL, Jernigan AM, Flocke SA, Tergas AI, Gunderson CC, Huh WK, Wilkinson-Ryan I, Lawson PJ, Fader AN, Belinson JL. Intimate Partner Violence and Barriers to Cervical Cancer Screening: A Gynecologic Oncology Fellow Research Network Study. J Low Genit Tract Dis. 2016 Jan; 20(1):47-51. PMID: 26704329.
      Citations: 5     Fields:    Translation:Humans
    31. Gunderson CC, Moore KN. BRACAnalysis CDx as a companion diagnostic tool for Lynparza. Expert Rev Mol Diagn. 2015; 15(9):1111-6. PMID: 26292709.
      Citations: 11     Fields:    Translation:Humans
    32. Gunderson CC, Boyd J, O'Malley DM. Highlights from the Society of Gynecologic Oncology 2015 Annual Meeting on Women's Cancer. Gynecol Oncol. 2015 Jul; 138(1):3-6. PMID: 26269805.
      Citations: 1     Fields:    Translation:Humans
    33. Walter AC, Gunderson CC, Vesely SK, Algan O, Sughrue M, Slaughter KN, Moore KN. Central nervous system metastasis in gynecologic cancer: symptom management, prognosis and palliative management strategies. Gynecol Oncol. 2015 Mar; 136(3):472-7. PMID: 25752572.
      Citations: 2     Fields:    Translation:Humans
    34. Gunderson CC, Moore KN. Olaparib: an oral PARP-1 and PARP-2 inhibitor with promising activity in ovarian cancer. Future Oncol. 2015; 11(5):747-57. PMID: 25757679.
      Citations: 21     Fields:    Translation:HumansAnimals
    35. Gunderson CC, Moore KN. PARP inhibition in ovarian cancer: state of the science. Gynecol Oncol. 2015 Jan; 136(1):8-10. PMID: 25554012.
      Citations: 1     Fields:    Translation:Humans
    36. Gunderson CC, Thomas ED, Slaughter KN, Farrell R, Ding K, Farris RE, Lauer JK, Perry LJ, McMeekin DS, Moore KN. The survival detriment of venous thromboembolism with epithelial ovarian cancer. Gynecol Oncol. 2014 Jul; 134(1):73-7. PMID: 24793732.
      Citations: 10     Fields:    Translation:Humans
    37. Gunderson CC, Java J, Moore KN, Walker JL. The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study. Gynecol Oncol. 2014 Apr; 133(1):23-7. PMID: 24680587.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    38. Gunderson CC, Dutta S, Fader AN, Maniar KP, Nasseri-Nik N, Bristow RE, Diaz-Montes TP, Palermo R, Kurman RJ. Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy. Gynecol Oncol. 2014 Jan; 132(1):33-7. PMID: 24316307.
      Citations: 9     Fields:    Translation:Humans
    39. Gunderson CC, Nugent EK, Yunker AC, Rocconi RP, Graybill WS, Erickson BK, Moore KN. Vaginal cancer: the experience from 2 large academic centers during a 15-year period. J Low Genit Tract Dis. 2013 Oct; 17(4):409-13. PMID: 23609592.
      Citations: 4     Fields:    Translation:Humans
    40. Gunderson CC, Tergas AI, Fleury AC, Diaz-Montes TP, Giuntoli RL. Primary uterine cancer in Maryland: impact of distance on access to surgical care at high-volume hospitals. Int J Gynecol Cancer. 2013 Sep; 23(7):1244-51. PMID: 23899587.
      Citations: 4     Fields:    Translation:Humans
    41. Gunderson CC, Nugent EK, McMeekin DS, Moore KN. Distance traveled for treatment of cervical cancer: who travels the farthest, and does it impact outcome? Int J Gynecol Cancer. 2013 Jul; 23(6):1099-103. PMID: 23765207.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    42. Gunderson CC, Farrell R, Dinh BC, Thomas ED, Vesely SK, Lauer JK, Kao L, Chopra S, McMeekin DS, Moore KN. Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful? Gynecol Oncol. 2013 Sep; 130(3):411-5. PMID: 23791827.
      Citations: 1     Fields:    Translation:Humans
    43. Gunderson CC, Nugent EK, Elfrink SH, Gold MA, Moore KN. A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia. Am J Obstet Gynecol. 2013 May; 208(5):410.e1-6. PMID: 23380265.
      Citations: 11     Fields:    Translation:Humans
    44. Gunderson CC, Fader AN, Carson KA, Bristow RE. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2012 May; 125(2):477-82. PMID: 22245711.
      Citations: 65     Fields:    Translation:Humans
    45. Gunderson CC, Knight J, Ybanez-Morano J, Ritter C, Escobar PF, Ibeanu O, Grumbine FC, Bedaiwy MA, Hurd WW, Fader AN. The risk of umbilical hernia and other complications with laparoendoscopic single-site surgery. J Minim Invasive Gynecol. 2012 Jan-Feb; 19(1):40-5. PMID: 22033285.
      Citations: 19     Fields:    Translation:Humans
    46. Ghomi A, Cohen SL, Chavan N, Gunderson C, Einarsson J. Laparoscopic-assisted vaginal hysterectomy vs laparoscopic supracervical hysterectomy for treatment of nonprolapsed uterus. J Minim Invasive Gynecol. 2011 Mar-Apr; 18(2):205-10. PMID: 21354066.
      Citations:    Fields:    Translation:Humans
    47. Fader AN, Levinson KL, Gunderson CC, Winder AD, Escobar PF. Laparoendoscopic single-site surgery in gynaecology: A new frontier in minimally invasive surgery. J Minim Access Surg. 2011 Jan; 7(1):71-7. PMID: 21197247.
      Citations:    
    48. Fader AN, Cohen S, Escobar PF, Gunderson C. Laparoendoscopic single-site surgery in gynecology. Curr Opin Obstet Gynecol. 2010 Aug; 22(4):331-8. PMID: 20592589.
      Citations: 16     Fields:    Translation:Humans
    Gunderson's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (216)
    Explore
    _
    Co-Authors (30)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _